16 September 2020
Virtual Property Tour
Today, Assura plc ("Assura") is hosting a Virtual Property Tour of two recent development completions for analysts and investors. No new material trading information will be disclosed.
In the financial year to date, Assura has completed construction on five development schemes (total cost £29 million). Work has commenced on a further six increasing the number of schemes currently on site to 16 (total cost £83 million). The Group has a strong pipeline of opportunities, with the immediate pipeline currently standing at 17 schemes (total cost £76 million) where we would expect to be on site in the next 12 months. This strong development pipeline is driven by our experienced and specialist in-house team, and our commitment to create the outstanding spaces for health services that communities across the country so urgently need.
A copy of the presentation will be available on the Assura plc website from 1pm today at https://www.assuraplc.com/investor-relations/reports-and-presentations.
- Ends -
For more information, please contact:
David Purcell, Head of Financial Reporting
Tel: 01925 420680
Email: [email protected]
Tel: 0207 251 3801
Email: [email protected]
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2020, Assura's property portfolio was valued at £2,139 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the London Stock Exchange
. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom
. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected]
or visit www.rns.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange